This country profile provides an overview of Eritrea’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage decreased from 88% in 2018 to 86% in 2019.
Treatment coverage increased from 0% in 2018 to 23% in 2019.
Eritrea does not require mass treatment for intestinal worms.
Treatment coverage increased from 53% in 2018 to 93% in 2019.
Eritrea does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Eritrea.